Use of long‐acting cabotegravir and rilpivirine in people living with <scp>HIV</scp> : A prospective observational cohort study

CAB+RPV LA appears to be an effective, safe and durable option for a switch strategy.

Authors

Institutions

Publication Details

Journal
HIV Medicine
Published
2026-03-26
DOI
https://doi.org/10.1111/hiv.70230
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of long‐acting cabotegravir and rilpivirine in people living with HIV : A prospective observational cohort study

Alicia Lázaro, M.C. Durán Torralba, Alberto Delgado, Ana Codonal et al.
HIV Medicine
HIV/AIDS drug development and treatment
article

Use of long‐acting cabotegravir and rilpivirine in people living with HIV : A prospective observational cohort study

Alicia Lázaro, M.C. Durán Torralba, Alberto Delgado, Ana Codonal, Elena Martínez
article en

Abstract

CAB+RPV LA appears to be an effective, safe and durable option for a switch strategy.

HIV Medicine
Universidad de Alcalá (ES), Hospital Universitario de Guadalajara (ES), Servicio de Salud de Castilla La Mancha (ES), Hospital Universitari Sant Joan de Reus (ES), University of Castilla-La Mancha (ES)
Zero hunger
Openalex Percentile: Top 8%
HIV/AIDS drug development and treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.